AAAAAA
Results: 1-25/31
Authors:
PALVIMAKI EP
MAJASUO H
KUOPPAMAKI M
MANNISTO PT
SYVALAHTI E
HIETALA J
Citation: Ep. Palvimaki et al., DERAMCICLANE, A PUTATIVE ANXIOLYTIC DRUG, IS A SEROTONIN 5-HT2C RECEPTOR INVERSE AGONIST BUT FAILS TO INDUCE 5-HT2C RECEPTOR DOWN-REGULATION, Psychopharmacology, 136(2), 1998, pp. 99-104
Authors:
TIIHONEN J
VILKMAN H
RASANEN P
RYYNANEN OP
HAKKO H
BERGMAN J
HAMALAINEN T
LAAKSO A
HAAPARANTASOLIN M
SOLIN O
KUOPPAMAKI M
SYVALAHTI E
HIETALA J
Citation: J. Tiihonen et al., STRIATAL PRESYNAPTIC DOPAMINE FUNCTION IN TYPE-1 ALCOHOLICS MEASURED WITH POSITRON-EMISSION-TOMOGRAPHY, Molecular psychiatry, 3(2), 1998, pp. 156-161
Authors:
KAJANDER J
VILKMAN H
SYVALAHTI E
NAGREN K
HIETALA J
Citation: J. Kajander et al., EFFECTS OF REPEATED FLUOXETINE TREATMENT ON STRIATAL D-2 DOPAMINE BINDING IN HUMANS, MEASURED WITH POSITRON-EMISSION-TOMOGRAPHY, Nordic journal of psychiatry, 52(2), 1998, pp. 121-122
Authors:
TAIMINEN TJ
SALOKANGAS RKR
SAARIJARVI S
NIEMI H
LEHTO H
AHOLA V
SYVALAHTI E
Citation: Tj. Taiminen et al., SMOKING AND COGNITIVE DEFICITS IN SCHIZOPHRENIA - A PILOT-STUDY, Addictive behaviors, 23(2), 1998, pp. 263-266
Authors:
POHJALAINEN T
RINNE JO
NAGREN K
SYVALAHTI E
HIETALA J
Citation: T. Pohjalainen et al., SEX-DIFFERENCES IN THE STRIATAL DOPAMINE D-2 RECEPTOR-BINDING CHARACTERISTICS IN-VIVO, The American journal of psychiatry, 155(6), 1998, pp. 768-773
Authors:
HIETALA J
KUOPPAMAKI M
NAGREN K
LEHIKOINEN P
SYVALAHTI E
Citation: J. Hietala et al., EFFECTS OF LORAZEPAM ADMINISTRATION ON STRIATAL DOPAMINE D-2 RECEPTOR-BINDING CHARACTERISTICS IN MAN - A POSITRON EMISSION TOMOGRAPHY STUDY, Psychopharmacology, 132(4), 1997, pp. 361-365
Authors:
SALOKANGAS RKR
SAARIJARVI S
TAIMINEN T
LEHTO H
NIEMI H
AHOLA V
SYVALAHTI E
Citation: Rkr. Salokangas et al., EFFECT OF SMOKING ON NEUROLEPTICS IN SCHIZOPHRENIA, Schizophrenia research, 23(1), 1997, pp. 55-60
Authors:
GACSALYI I
SCHMIDT E
GYERTYAN I
VASAR E
LANG A
HAAPALINNA A
FEKETE M
HIETALA J
SYVALAHTI E
TUOMAINEN P
MANNISTO PT
Citation: I. Gacsalyi et al., RECEPTOR-BINDING PROFILE AND ANXIOLYTIC-TYPE ACTIVITY OF DERAMCICLANE(EGIS-3886) IN ANIMAL-MODELS, Drug development research, 40(4), 1997, pp. 333-348
Authors:
TAIMINEN TJ
SYVALAHTI E
SAARIJARVI S
NIEMI H
LEHTO H
AHOLA V
SALOKANGAS RKR
Citation: Tj. Taiminen et al., CITALOPRAM AS AN ADJUVANT IN SCHIZOPHRENIA - FURTHER EVIDENCE FOR A SEROTONERGIC DIMENSION IN SCHIZOPHRENIA, International clinical psychopharmacology, 12(1), 1997, pp. 31-35
Authors:
TAIMINEN T
SYVALAHTI E
SAARIJARVI S
NIEMI H
LEHTO H
AHOLA V
SALOKANGAS RKR
Citation: T. Taiminen et al., IS POSITIVE PLACEBO-RESPONSE IN CHRONIC-SCHIZOPHRENIA INVESTIGATOR-DEPENDENT, The Journal of nervous and mental disease, 185(10), 1997, pp. 644-645
Authors:
POHJALAINEN T
CRAVCHIK A
GEJMAN PV
RINNE J
NAGREN K
SYVALAHTI E
HIETALA J
Citation: T. Pohjalainen et al., ANTAGONIST BINDING CHARACTERISTICS OF THE SER(311)-]CYS VARIANT OF HUMAN DOPAMINE D-2 RECEPTOR IN-VIVO AND IN-VITRO, Biochemical and biophysical research communications, 232(1), 1997, pp. 143-146
Authors:
TIIHONEN J
KUOPPAMAKI M
NAGREN K
BERGMAN J
ERONEN E
SYVALAHTI E
HIETALA J
Citation: J. Tiihonen et al., SEROTONERGIC MODULATION OF STRIATAL D-2 DOPAMINE-RECEPTOR BINDING IN HUMANS MEASURED WITH POSITRON EMISSION TOMOGRAPHY, Psychopharmacology, 126(4), 1996, pp. 277-280
Authors:
PALVIMAKI EP
ROTH BL
MAJASUO H
LAAKSO A
KUOPPAMAKI M
SYVALAHTI E
HIETALA J
Citation: Ep. Palvimaki et al., INTERACTIONS OF SELECTIVE SEROTONIN REUPTAKE INHIBITORS WITH THE SEROTONIN 5-HT2C RECEPTOR, Psychopharmacology, 126(3), 1996, pp. 234-240
Authors:
LAAKSO A
PALVIMAKI EP
KUOPPAMAKI M
SYVALAHTI E
HIETALA J
Citation: A. Laakso et al., CHRONIC CITALOPRAM AND FLUOXETINE TREATMENTS UP-REGULATE 5-HT2C RECEPTORS IN THE RAT CHOROID-PLEXUS, Neuropsychopharmacology, 15(2), 1996, pp. 143-151
Authors:
LEHTINEN V
AALTONEN J
KOFFERT T
RAKKOLAINEN V
SYVALAHTI E
VUORIO K
Citation: V. Lehtinen et al., INTEGRATED TREATMENT MODEL FOR FIRST-CONTACT PATIENTS WITH A SCHIZOPHRENIA-TYPE PSYCHOSIS - THE FINNISH API PROJECT, Nordic journal of psychiatry, 50(4), 1996, pp. 281-287
Authors:
HIETALA J
SYVALAHTI E
Citation: J. Hietala et E. Syvalahti, DOPAMINE IN SCHIZOPHRENIA, Annals of medicine, 28(6), 1996, pp. 557-561
Authors:
TAIMINEN T
SYVALAHTI E
SAARIJARVI S
NIEMI H
LEHTO H
AHOLA V
SALOKANGAS RKR
Citation: T. Taiminen et al., PREDICTION OF POSITIVE PLACEBO-RESPONSE AMONG CHRONIC-SCHIZOPHRENIC OUTPATIENTS, The Journal of nervous and mental disease, 184(2), 1996, pp. 109-113
Authors:
WONG G
KUOPPAMAKI M
HIETALA J
LUDDENS H
SYVALAHTI E
KORPI ER
Citation: G. Wong et al., EFFECTS OF CLOZAPINE METABOLITES AND CHRONIC CLOZAPINE TREATMENT ON RAT-BRAIN GABA(A) RECEPTORS, European journal of pharmacology, 314(3), 1996, pp. 319-323
Authors:
SALOKANGAS RKR
SAARIJARVI S
TAIMINEN T
KALLIONIEMI H
LEHTO H
NIEMI H
TUOMINEN J
AHOLA V
SYVALAHTI E
Citation: Rkr. Salokangas et al., CITALOPRAM AS AN ADJUVANT IN CHRONIC-SCHIZOPHRENIA - A DOUBLE-BLIND PLACEBO-CONTROLLED STUDY, Acta psychiatrica Scandinavica, 94(3), 1996, pp. 175-180
Authors:
KUOPPAMAKI M
PALVIMAKI EP
HIETALA J
SYVALAHTI E
Citation: M. Kuoppamaki et al., DIFFERENTIAL REGULATION OF RAT 5-HT2A AND 5-HT2C RECEPTORS AFTER CHRONIC TREATMENT WITH CLOZAPINE, CHLORPROMAZINE AND 3 PUTATIVE ATYPICAL ANTIPSYCHOTIC-DRUGS, Neuropsychopharmacology, 13(2), 1995, pp. 139-150
Authors:
HIETALA J
SYVALAHTI E
VUORIO K
RAKKOLAINEN V
BERGMAN J
HAAPARANTA M
SOLIN O
KUOPPAMAKI M
KIRVELA O
RUOTSALAINEN U
SALOKANGAS RKR
Citation: J. Hietala et al., PRESYNAPTIC DOPAMINE FUNCTION IN STRIATUM OF NEUROLEPTIC-NAIVE SCHIZOPHRENIC-PATIENTS, Lancet, 346(8983), 1995, pp. 1130-1131
Authors:
PALVE H
KIRVELA O
OLIN H
SYVALAHTI E
KANTO J
Citation: H. Palve et al., MAXIMUM RECOMMENDED DOSES OF LIGNOCAINE ARE NOT TOXIC, British Journal of Anaesthesia, 74(6), 1995, pp. 704-705
Authors:
LONNQVIST J
SIHVO S
SYVALAHTI E
SINTONEN H
KIVIRUUSU O
PITKANEN H
Citation: J. Lonnqvist et al., MOCLOBEMIDE AND FLUOXETINE IN THE PREVENTION OF RELAPSES FOLLOWING ACUTE TREATMENT OF DEPRESSION, Acta psychiatrica Scandinavica, 91(3), 1995, pp. 189-194
Authors:
HIETALA J
WEST C
SYVALAHTI E
NAGREN K
LEHIKOINEN P
SONNINEN P
RUOTSALAINEN U
Citation: J. Hietala et al., STRIATAL D-2 DOPAMINE-RECEPTOR BINDING CHARACTERISTICS IN-VIVO IN PATIENTS WITH ALCOHOL DEPENDENCE, Psychopharmacology, 116(3), 1994, pp. 285-290
Authors:
PALVIMAKI EP
LAAKSO A
KUOPPAMAKI M
SYVALAHTI E
HIETALA J
Citation: Ep. Palvimaki et al., UP-REGULATION OF BETA(1)-ADRENERGIC RECEPTORS IN RAT-BRAIN AFTER CHRONIC CITALOPRAM AND FLUOXETINE TREATMENTS, Psychopharmacology, 115(4), 1994, pp. 543-546